The positive preliminary SENTI-202 clinical data was presented on April 27 in a Clinical Trials Oral Minisymposium at the American Association for Cancer Research (AACR) Annual Meeting 2025 in an ...
Immunotherapy has transformed the treatment of many cancers, but one of its biggest hurdles remains on-target toxicity—the unintended destruction of healthy cells that share surface markers with ...
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback